Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Accurate expert analysis for a fragmented market

timely news deep insight pharma intelligence

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

See how we can help you get ahead in the competitive medtech environment: watch the video

Relevant products

Medtech Insight: global medical technology news & analysis

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Key benefits:

Real-time news and analysis
Regulatory development news
Company development news

Meddevicetracker: medical device intelligence and forecasts

In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

Key benefits:

Real-time market intelligence
Medical device market coverage
Discover new opportunities

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

Cutting edge thought leadership
Expert analysis
Hear from news makers

Medtech Insight

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

By Ashley Yeo 11 Dec 2019

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.

View analysis
In Vivo

Medtechs Enter The Decade of Digital, Consumers and Wellness

By Ashley Yeo 11 Dec 2019

For providers and medtech manufacturers alike, the decade ahead will be a time of coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market entry criterion, but companies will have to adapt to evolving health care delivery models. The stakes are implausibly high. Will they be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?

View analysis
Medtech Insight

Has EU Sorted Expert Panels As Tsunami Of 700 Applications Pour In After Extended Deadline?

By Amanda Maxwell 11 Dec 2019

Only just over a month ago there were fears that the implementation of the EU Medical Device Regulation was going to be hampered by a lack of expert panel applicants. Now it seems there is no shortage. The news raises lots of questions about when and how the structure will now work.

View article
In Vivo

Critical Insights into Market Access

10 Dec 2019

Your key to refining your market access strategy with essential patient market access mini-mag and infographic from the experts at In Vivo.

View infographic
In Vivo

Brexit To And Fro Continues Into Fresh Decade

By Ian Schofield 06 Dec 2019

Three Brexit deadlines have come and gone, and the UK is still a member of the European Union. It will remain so until it agrees a withdrawal deal or leaves without one at the end of January 2020. Alternatively, it could secure yet another extension to the Article 50 period beyond January 31. Or it could decide not to leave at all.

Topic Business Strategies Policy and regulation

View analysis
Medtech Insight

Execs On The Move: New Research Chief At Biovica; Convergent Dental And XACT Robotics Find Sales VPs

06 Dec 2019

Swedish cancer diagnostics firm Biovica International announces a new R&D director; Convergent Dental, a dental equipment company, and XACT Robotics, a robotics system developer, pick sales veeps; and more.

Topic Medtech

View article
Medtech Insight

Competent Authorities Drive Unilateral Eudamed Delay Decision Onto Council Of EU Agenda

By Amanda Maxwell 06 Dec 2019

The two-year delay to Eudamed was a Commission decision. Now the competent authorities are fighting back and the issue is to be discussed at the level of the Council of the European Union on December 9 to avoid “heavily burdensome administrative transitional solutions.”

View article
In Vivo

From US To EU: Young Biotechs Going It Alone

By Jo Shorthouse 28 Nov 2019

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

View analysis
Medtech Insight

Landmark Date Highlights Major Problems In Implementing IVDR As Well As MDR

By Amanda Maxwell 27 Nov 2019

There may have been a significant increase in the amount of regulatory activity at EU level of late, but the medtech industry remains alarmed at the lack of readiness of the system, and calls for an urgent focus on IVDs now too.

View article
Medtech Insight

FDA Launches Pilot Program To Streamline EtO Facility, Process Changes

By Ferdous Al-Faruque 27 Nov 2019

As concerns continue to mount over a potential shortage of medical devices due to the closure of ethylene oxide (EtO) facilities, the US agency is looking for nine sterilizers in a pilot project that could allow them to get facility and process changes approved faster.

View article
In Vivo

MHealth And Research In Oncology

By Niharika Dandamudi 20 Nov 2019

The World Health Organization defines mobile health (mHealth) as a “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices.”

Topic Digital Health Personalized Medicine

View analysis
Medtech Insight

CooperVision Nabs Approval On Pediatric Contact Lens

By Elizabeth Orr 20 Nov 2019

A newly approved contact lens from CooperVision promises to slow the progression of nearsightedness when prescribed to children aged 8 to 12.

Topic FDA

View article
Medtech Insight

Recipharm Boosts Inhalation And Injectables Manufacturing By Acquiring UK's Consort Medical

By Marion Webb 20 Nov 2019

Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company and top five global CDMO.

Topic Deal trends

View article
Medtech Insight

Senators Question FDA's Proposed Progressive Approval Pathway For Devices

By Sue Darcey 13 Nov 2019

US Democratic Sens. Elizabeth Warren of Massachusetts and Patty Murray of Washington State recently sent a letter to FDA officials Brett Giroir and Jeff Shuren that raises doubts about a planned bill calling for a progressive approval pathway for medical devices.

Topic FDA Policy and regulation

View article
Medtech Insight

FDA Will Have To Scrape By On Continuing Resolution Funding Through December, Legislative Experts Predict

By Sue Darcey 13 Nov 2019

While a government agency shutdown due to lack of agreement between Congress and the Trump administration over funding for the US Food and Drug Administration and other federal agencies seems less likely this year than last, the FDA will still have carry out its 2020 mission in the short term on 2019 continuing resolution funding – probably through December – legislative experts say.

Topic FDA Policy and regulation

View article